A Real-world Registry Study of Multidisciplinary Collaborative Diagnosis and Treatment Model for Cardioembolic Stroke
This study aimed to establish a multidisciplinary assisted diagnosis and treatment model for patients at high risk of cardioembolic stroke, manage and collect the diagnosis, treatment and prognosis data of patients. Between September 2022 and September 2023, around 1,200 patients at high risk of cardioembolic stroke were enrolled into the study from the Second Affiliated Hospital of Nanchang University and sub-centres of hospitals at all levels in Jiangxi Province, China. Participants were followed for up to two years to determine the course and outcome of cardioembolic stroke.
Study design
Registry, Cohort - clinical, Cohort
Number of participants at first data collection
~1,200 (participants)
Age at first data collection
Varied (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2022
Primary Institutions
Second Affiliated Hospital of Nanchang University (南昌大学第二附属医院, SAHNU) (Healthcare/Medical, China)
Profile paper DOI
cdn.clinicaltrials.gov/large-docs/09/NCT05498909/Prot_000.pdf
Funders
No funding information available
Ongoing?
No
Data types collected
- Activity log (e.g. food, sleep, exercise)
- Interview – unspecified
- Secondary data
- None
- Computerized tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Healthcare data
- Mortality data
Engagement
Keywords
